| Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer E Eriksson, J Wenthe, S Irenaeus, A Loskog, G Ullenhag Journal of Translational Medicine 14, 1-12, 2016 | 192 | 2016 |
| Shaping the tumor stroma and sparking immune activation by CD40 and 4-1BB signaling induced by an armed oncolytic virus E Eriksson, I Milenova, J Wenthe, M Ståhle, J Leja-Jarblad, G Ullenhag, ... Clinical Cancer Research 23 (19), 5846-5857, 2017 | 141 | 2017 |
| The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma L Ny, H Jespersen, J Karlsson, S Alsén, S Filges, C All-Eriksson, ... Nature communications 12 (1), 5155, 2021 | 110 | 2021 |
| Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte … GJ Ullenhag, JE Frödin, M Jeddi-Tehrani, K Strigård, E Eriksson, ... Clinical cancer research 10 (10), 3273-3281, 2004 | 108 | 2004 |
| Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results S Mosolits, G Ullenhag, H Mellstedt Annals of oncology 16 (6), 847-862, 2005 | 99 | 2005 |
| Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony … GJ Ullenhag, JE Frödin, S Mosolits, S Kiaii, M Hassan, MC Bonnet, ... Clinical cancer research 9 (7), 2447-2456, 2003 | 86 | 2003 |
| First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies SMM Irenaeus, D Nielsen, P Ellmark, J Yachnin, A Deronic, A Nilsson, ... International journal of cancer 145 (5), 1189-1199, 2019 | 81 | 2019 |
| Treatment of metastatic malignant melanoma with vemurafenib during pregnancy A Maleka, G Enblad, G Sjörs, A Lindqvist, G Ullenhag Journal of Clinical Oncology 31 (11), e192-e193, 2013 | 72 | 2013 |
| Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment E Eriksson, R Moreno, I Milenova, L Liljenfeldt, LC Dieterich, ... Gene therapy 24 (2), 92-103, 2017 | 71 | 2017 |
| Mortality in women with pregnancy-associated malignant melanoma ALV Johansson, TML Andersson, A Plym, GJ Ullenhag, H Møller, ... Journal of the American Academy of Dermatology 71 (6), 1093-1101, 2014 | 68 | 2014 |
| Discrepancy in BRAF status among patients with metastatic malignant melanoma: A meta-analysis A Valachis, GJ Ullenhag European Journal of Cancer 81, 106-115, 2017 | 61 | 2017 |
| Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study D Schadendorf, MM Amonkar, M Milhem, K Grotzinger, LV Demidov, ... Annals of oncology 25 (3), 700-706, 2014 | 58 | 2014 |
| Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study H Jespersen, R Olofsson Bagge, G Ullenhag, A Carneiro, H Helgadottir, ... BMC cancer 19, 1-7, 2019 | 52 | 2019 |
| Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients A Loskog, A Maleka, S Mangsbo, E Svensson, C Lundberg, A Nilsson, ... British journal of cancer 114 (8), 872-880, 2016 | 48 | 2016 |
| Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients A Schiza, J Wenthe, S Mangsbo, E Eriksson, A Nilsson, TH Tötterman, ... Journal of translational medicine 15, 1-11, 2017 | 47 | 2017 |
| A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55 GJ Ullenhag, I Spendlove, NFS Watson, AA Indar, M Dube, RA Robins, ... Clinical cancer research 12 (24), 7389-7396, 2006 | 46 | 2006 |
| A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma G Gremel, D Djureinovic, M Niinivirta, A Laird, O Ljungqvist, ... BMC cancer 17, 1-9, 2017 | 42 | 2017 |
| A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib A Maleka, G Åström, P Byström, GJ Ullenhag BMC cancer 16, 1-5, 2016 | 40 | 2016 |
| Trends in cutaneous malignant melanoma in Sweden 1997–2011: thinner tumours and improved survival among men J Lyth, H Eriksson, J Hansson, C Ingvar, M Jansson, J Lapins, ... British Journal of Dermatology 172 (3), 700-706, 2015 | 40 | 2015 |
| Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial R Olofsson, L Ny, MS Eilard, M Rizell, C Cahlin, U Stierner, U Lönn, ... Trials 15, 1-6, 2014 | 40 | 2014 |
